10429_infocus_parkinson_bw_17_tot

35. Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairmentin Parkinson’s disease: Movement Disorder Society Task Force guidelines.Mov Disord. 2012;27:349-56.36. Mattila PM, Rinne JO, Helenius H, et al. Alphasynuclein-immunoreactive corticalLewy bodies are associated with cognitive impairment in Parkinson’s disease. ActaNeuropathol. 2000;100:285-90.37. Laakso MP, Partanen K, Riekkinen P, et al. Hippocampal volumes in Alzheimer’sdisease, Parkinson’s disease with or without dementia: an MRI study. Neurology.1996;46:678-81.38. Draijer LW, Eizenga WH, Sluiter A. NHG-standaard Ziekte van Parkinson. HuisartsWet. 2011;54:380-92.39. Santangelo G, Barone P, Trojano L, Vitale C. Pathological gambling in Parkinson’sdisease. A comprehensive review. Parkinsonism Relat Disord. 2013;19:645-53.40. Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placementin Parkinson’s disease: a population-based, prospective study. J Am Geriatr Soc.2000;48:938-42.41. Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson’s disease: prevalence,phenomenology, and risk factors. Brain. 2000;123:733-45.42. Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkisnon’sdisease as disturbed external/internal perceptions: focused review and a new integrativemodel. Mov Disord. 2005;20:130-40.43. Onofrj M, Thomas A, D’Andreamatteo G, et al. Incidence of RBD and hallucinationin patients affected by Parkinson’s disease: 8-year follow-up. Neurol Sci.2002;23(suppl 2):S91-94.44. Moskovitz C, Moses H, Klawans HL. Levodopa-induced psychosis: a kindling phenomenon.Am J Psychiatry. 1978;135:669-75.45. Pezzella FR, Colosimo C, Vanacore N, et al. Prevalence and clinical features of hedonistichomeostatic dysregulation in Parkinson’s disease. Mov Disord. 2005;20:77-81.46. Müller T. Drug therapy in patients with Parkinson’s disease. Transl Neurodegener.2012;1:10.47. Kipps CM, Fung VSC, Grattan-Smith P, et al. Movement disorder emergencies. MovDisord. 2005;20:322-34.48. Bloem BR, van Laar T, Keus SHJ, et al. Multidisciplinaire richtlijn ziekte vanParkinson. Alphen a/d Rijn: Van Zuiden Communications. 2010.49. Chaudhuri KR. Nocturnal symptom complex in PD and its management. Neurology.2003;61(Supp 3):S17-S23.50. Garcia-Borreguero D, Larosa O, Bravo M. Parkinson’s disease and sleep. SleepMed Rev. 2003;7:115-29.51. Louter M, Aarden WC, Lion J, et al. Recognition and diagnosis of sleep disorders inParkinson’s disease. J Neurol. 2012;259:2031-40.52. Raggi A, Bella R, Pennisi G, et al. Sleep disorders in Parkinson’s disease: anarrative review of the literature. Rev Neurosci. 2013;24:279-91.InFocus Niet-motorische verschijnselen bij de ziekte van Parkinson 77